Lovastatin
Back to searchMolecule Structure
Scientific Name
Lovastatin
Description of the Drug
Lovastatin is an HMG-CoA reductase inhibitor used to lower LDL cholesterol and reduce the risk of cardiovascular disease and associated conditions, including myocardial infarction and stroke.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00227
http://www.drugbank.ca/drugs/DB00227
Brand Name(s)
Altoprev, Lovastatin, Mevacor, Mevinacor, Mevinacor 10, Mevinacor 40
Company Owner(s)
Teva Pharmaceuticals Usa Inc, Merck Research Laboratories Div Merck Co Inc, Sun Pharmaceutical Industries Inc, Covis Pharma Gmbh, Chartwell Rx Sciences Llc, Epic Pharma Inc, Actavis Elizabeth Llc, Abbvie Inc, Corepharma Llc, Mylan Pharmaceuticals Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
HMG-CoA reductase | SINGLE PROTEIN | INHIBITOR | CHEMBL402 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL3136 | ||
PharmGKB | PA450272 | ||
Human Metabolome Database | HMDB0014372 | ||
DrugBank | DB00227 | ||
PubChem: Thomson Pharma | 14806053 | 14879393 | |
PubChem | 53232 | ||
Mcule | MCULE-4740518260 | MCULE-7087866108 | |
NMRShiftDB | 60027498 | ||
LINCS | LSM-2189 | ||
Nikkaji | J22.276C | ||
PDBe | 803 | ||
BindingDB | 34168 | ||
EPA CompTox Dashboard | DTXSID5020784 | ||
DrugCentral | 1612 | ||
Metabolights | MTBLC40303 | ||
Brenda | 17608 | 111182 | |
Rhea | 40303 | ||
Guide to Pharmacology | 2739 | ||
rxnorm | MEVACOR | ALTOPREV | LOVASTATIN |
PubChem: Drugs of the Future | 12012664 | ||
KEGG Ligand | C07074 | ||
ChEBI | 40303 | ||
ZINC | ZINC000003812841 |